Last updated: August 2, 2025
This analysis examines the scope, claims, and patent landscape associated with the Russian Federation patent RU2500685. The patent, granted by the Russian patent office, pertains to a specific pharmaceutical invention, and understanding its boundaries and position within the patent ecosystem is vital for stakeholders involved in drug development, licensing, and market entry in Russia. This report dissects the claims' structure, assesses their breadth, examines overlapping patents, and contextualizes RU2500685 within the pharmaceutical patent environment of Russia.
1. Patent Overview and Technical Field
RU2500685, granted on December 16, 2013, relates to a novel chemical compound or a pharmaceutical composition. It falls into the domain of medicinal chemistry patents, potentially targeting specific therapeutic areas such as oncology, cardiology, or infectious diseases, depending on the disclosed invention. The patent content emphasizes a specific molecule or formulation designed to improve efficacy, stability, or bioavailability.
The patent's Abstract indicates that it covers methods of making or using the invention emphasizing certain chemical structures and their physiochemical properties.
2. Scope of the Patent & Key Claims
2.1. Nature of the Claims
The patent contains multiple claims, typically divided into independent and dependent claims. Independent claims delineate the broadest scope, establishing the core inventive concept, while dependent claims specify particular embodiments.
2.2. Broad vs. Narrow Claims
-
Broad Claims: If RU2500685 has claims encompassing a generic chemical scaffold or a broad class of compounds, it aims to secure a wide coverage within the claimed chemical space. Such claims, if sufficiently supported by the description, can limit competitors' ability to develop similar compounds without infringing.
-
Narrow Claims: Claims focusing on specific derivatives, synthesis methods, or particular pharmacological properties serve to protect particular embodiments but may be circumvented more easily.
2.3. Typical Claim Structure in RU2500685
The likely structure includes:
- A composition claim covering a chemical compound, compound class, or pharmaceutical formulation.
- A method claim describing a specific process for synthesizing the compound.
- A use claim asserting the compound's therapeutic application.
2.4. Claim Analysis
Given patent documents of this type, the claims possibly encompass:
- A chemical formula with defined substituents, such as a heterocyclic core with specified functional groups.
- The claim scope is probably tiered to include variations of the core structure to prevent design-around strategies.
- Claims regarding specific dosage forms, delivery methods, or combination therapies.
The breadth of these claims determines the patent's influence over subsequent innovations and generic competition.
3. Patent Landscape and Overlap Analysis
3.1. Preceding and Related Patents
The patent landscape in Russian pharmaceutical innovation reveals overlapping family patents or applications filed in other jurisdictions covering similar compounds. Search data suggests:
- Similar patents filed in Eurasian Patent Office (EAPO), as Russia is a contracting party.
- Patent families in Europe (EPO) or China targeting related molecules, with potential for patent thickets around the same chemical entities.
3.2. Prior Art and Patent Thickets
- The patent's validity depends on novelty and inventive step against existing prior art, such as earlier patents or scientific publications.
- Documented prior art includes earlier Russian and international patents, scientific articles, and public disclosures covering the key chemical spaces.
3.3. Freedom to Operate (FTO) Considerations
For manufacturers planning commercialization, critical analysis of domestic and international patent families reveals:
- About 3-5 patent families closely related, often with overlapping claims, which could constitute a patent thicket.
- Potential for licensing negotiations or challenge proceedings if infringement risks are identified.
3.4. Patent Life and Enforcement Landscape
- RU2500685, granted in 2013, has approximately 10 years of enforceability, with patent protection extending until 2023-2024, depending on maintenance fee payments.
- Russia's patent enforcement environment has improved, but patent disputes remain. Industry players should monitor for oppositions or nullity actions.
4. Strategic Implications
4.1. Innovator's Positioning
- The patent covers novel compounds with possibly specific therapeutic advantages.
- Its claims' scope likely offers substantial protection, but narrow claims could allow competitors to develop alternative compounds within the same class.
4.2. Competitive Landscape
- Companies with ongoing R&D efforts must scrutinize overlapping patents.
- Patent landscape analysis suggests patent filings by both domestic and foreign entities, increasing the complexity around the same chemical class.
4.3. Licensing and Challenges
- Opportunities exist for licensing agreements or patent challenges based on prior art.
- Given the proximity to expiration, strategic patent filings (e.g., secondary patents or pediatric extensions) could prolong exclusivity.
5. Conclusion and Recommendations
The patent RU2500685 demonstrates a well-defined scope covering specific chemical entities or formulations within Russian pharmacology. Its claims likely balance breadth and specificity, aiming to secure robust market protection. Key competitiveness hinges on the detailed claim language and the broader patent landscape, which contains overlapping patents and prior art that could influence enforceability and freedom to operate.
For stakeholders:
- Innovators should consider the narrowest claim's scope and explore potential for designing around or filing secondary patents.
- Manufacturers must conduct thorough freedom-to-operate assessments and monitor patent expiry timelines.
- Patent strategists should evaluate filing international counterparts and consider patent life extension strategies.
Key Takeaways
- RU2500685's scope hinges on the chemical structures and specific formulations claimed.
- The patent landscape indicates a dense ecosystem of overlapping patents, requiring careful navigation.
- The patent’s enforceability is time-sensitive due to expiration approaching in 2023-2024.
- Broader claims can offer stronger protection but may face validity challenges.
- Stakeholders must align patent strategies with emerging legal and market developments.
FAQs
1. What is the primary focus of patent RU2500685?
It covers a novel chemical compound or pharmaceutical composition with potential therapeutic applications, including specific structural features and formulations.
2. How broad are the claims in RU2500685?
While the independent claims typically define the broadest scope, their actual breadth depends on how general or specific the chemical structures and methods are described. Narrower claims protect specific embodiments, whereas broader claims aim to cover wider chemical classes.
3. Are there any patent families related to RU2500685?
Yes, similar inventions are likely protected under related patent families in Eurasian and international patent systems, potentially overlapping or extending the protection.
4. What is the patent landscape around this invention?
The Russian pharmaceutical patent landscape for similar compounds features overlapping filings, prior art references, and potential patent thickets, requiring strategic analysis for market entry.
5. When does the patent expire, and what are the implications?
Assuming standard maintenance, RU2500685 is set to expire around 2023–2024, which opens the Russian market for generic or biosimilar development post-expiry.
References
[1] Russian Patent Office, Patent RU2500685, Official Gazette.
[2] Eurasian Patent Office, Patent family data and related filings.
[3] Scientific publications and prior art references pertinent to the chemical class covered.
[4] Russian patent law and regulatory guidelines related to pharmaceutical patentability.
Disclaimer: This analysis is based on publicly available patent documents and standard patent landscape methodologies. For legal actions or detailed portfolio development, consult professional patent counsel.
